Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 12:04 AM
Study NCT ID:
NCT04894994
Status:
TERMINATED
Last Update Posted:
2023-12-05
First Post:
2021-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FLX475 in Combination With Ipilimumab in Advanced Melanoma
Sponsor:
RAPT Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-12
First Submit QC Date:
None
Study First Post Date:
2021-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-13
Results First Submit QC Date:
None
Results First Post Date:
2023-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2023-12-05
Last Update Post Date Type:
ACTUAL